The metabolism of platelet-activating factor in human T-lymphocytes

Jeffrey B. Travers, Howard Sprecher, Richard H. Fertel

Research output: Contribution to journalArticle

24 Scopus citations


The metabolism of 1-[3H]alkyl-2-acetyl-sn-glycero-3-phosphocholine (1-[3H]alky1-2-acetyl-GPC; platelet-activating factor; PAF) was investigated in purified human peripheral blood T-lymphocytes and a human leukemia cell line of T-cell origin (MOLT-4). The major metabolic products of T-lymphocyte PAF metabolism are 1-alky1-2-acyl-GPC, 1-alkyl-2-lyso-GPC and neutral lipid. The pattern of PAF metabolism in peripheral blood T-lymphocytes and MOLT-4 lymphoblasts was similar, although MOLT-4 lymphoblasts transformed PAF to 1-alky1-2-acyl-GPC faster than peripheral blood T-lymphocytes (67% vs. 21% of added label after 64 min at 37°C, respectively). Pre-exposure of MOLT-4 lymphoblasts to 1 mM of the serine hydrolase inhibitor phenylmethylsulfonyl fluoride resulted in an inhibition of PAF metabolism. Our results indicate that intact T-lymphocytes actively metabolize this biologically active phospholipid by the deacetylation-transacylation pathway.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalBiochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism
Issue number2
StatePublished - Feb 6 1990
Externally publishedYes


  • (Human T lymphocyte)
  • Alkylacetylglycerophosphocholine
  • Alkylacylglycerophosphocholine
  • Lyso-PAF
  • PAF

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Endocrinology

Fingerprint Dive into the research topics of 'The metabolism of platelet-activating factor in human T-lymphocytes'. Together they form a unique fingerprint.

  • Cite this